EyePoint Pharmaceuticals

Committee Composition

  Audit Compensation Governance and Nominating Science
Dr. David J. Mazzo Chairman of the Board Independent Director   Committee Chair for Compensation Committee Member of Governance and Nominating Committee Member of Science Committee
Mr. Michael W. Rogers Independent Director Committee Chair for Audit Committee Member of Compensation Committee    
Mr. Douglas Godshall Independent Director   Member of Compensation Committee Committee Chair for Governance and Nominating Committee  
Dr. James Barry Independent Director Member of Audit Committee     Member of Science Committee
Director

Dr. Barry has been the President and Chief Executive Officer of InspireMD, a global medical device company focused on the development and commercialization of vascular products, since June 2016 and has served on the board of directors of InspiredMD since January 2011. Prior to this, he served as the Executive Vice President and Chief Operating Officer of InspireMD. Prior to joining InspireMD, Dr. Barry served as Executive Vice President and Chief Operating Officer of Arsenal Medical from August 2011 until September 2012, and as President and CEO and Director from September 2012 until December 2013. Dr. Barry has been the Principal Founder at Convergent Biomedical Group since September 2010. Dr. Barry served in various executive and managerial positions at Boston Scientific Corporation, where he had been employed from 1992 until 2010, including as a member of Boston Scientific’s Operating Committee. From 2007 through 2010 he served as Senior Vice President, Corporate Technology Development, responsible for the global research and development function, and for the prior six years he served as Vice President, Corporate Research and Advanced Technology Development. Dr. Barry is also a director of AgNovos Healthcare LLC and Cardiac Implants and in the past also served as a director of MicroChips Corporation. Dr. Barry has a Bachelor of Arts in Chemistry from St. Anselm College and a Ph.D. in Biochemistry from the University of Massachusetts. We believe Dr. Barry is qualified to serve on our Board because his significant experience developing products, leading research and development teams and building successful businesses, coupled with his expertise in advising clients in the pharmaceutical, biotechnology and medical device industries, brings valuable technical expertise and commercial experience to our company.


Dr. Jay Duker Independent Director     Member of Governance and Nominating Committee Committee Chair for Science Committee
Ms. Kris Peterson Independent Director Member of Audit Committee   Member of Governance and Nominating Committee  
Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member Independent Director = Independent Director

Search Investor Relations

EyePoint Pharmaceuticals